Hong Kong Building Stock News

SEHK:992
SEHK:992Tech

Should Lenovo’s New AI Meeting Bundles Reshape Its Enterprise Collaboration Story for Lenovo Group (SEHK:992) Investors?

Lenovo announced at ISE 2026 a new series of AI-powered full-room meeting solutions built on ThinkSmart Core Gen 2 and Huddly’s intelligent audio-video devices, offering unified management and consistent Microsoft Teams Rooms and Zoom Room experiences across different room sizes. By tightly integrating AI-optimized compute, modular multi-camera systems, and centralized device management, Lenovo is positioning its ThinkSmart-Huddly bundles as comprehensive infrastructure for more inclusive...
SEHK:1211
SEHK:1211Auto

Is BYD (SEHK:1211) Now Attractive After Recent Share Price Weakness?

Wondering if BYD at HK$91.0 is a fair entry point or if the price is out of line with its fundamentals? This article walks through that question step by step so you can judge the value for yourself. BYD's share price is currently around HK$91.0, with a 7.6% decline over the last week and a 7.8% decline over the last month, while the 1 year return sits at 0.5% and the 3 and 5 year returns are 14.6% and 12.8% respectively. Recent headlines around BYD have focused on its role in the global...
SEHK:17
SEHK:17Real Estate

Is New World Development (SEHK:17) Now Fairly Priced After Its 1‑Year 143% Rally?

If you are wondering whether New World Development offers value at its current price, you are not alone, especially given how sharply the stock has been moving. The share price closed at HK$10.02, with returns of 1.9% over 7 days, 35.6% over 30 days, 35.6% year to date, and 142.6% over 1 year. The 3 year and 5 year returns sit at 49.5% and 60.1% declines. These moves have come as investors refocus on Hong Kong property developers and reassess balance sheet strength and asset values across...
SEHK:3696
SEHK:3696Life Sciences

Insilico Medicine Advances AI Drug Discovery Model With New Partnerships

Insilico Medicine Cayman TopCo (SEHK:3696) has secured a partnership with Qilu Pharmaceutical focused on cardiometabolic disease drug candidates. The company received FDA IND clearance for a novel NLRP3 inhibitor, ISM8969, targeting Parkinson's Disease. Insilico launched its Science MMAI Gym to make its AI tools available to pharma R&D partners. A global co development agreement for ISM8969 was signed with Hygtia Therapeutics, expanding the candidate's reach. For investors tracking AI...
SEHK:1810
SEHK:1810Tech

Is Xiaomi (SEHK:1810) Pricing Look Attractive After Recent Share Price Weakness

Wondering whether Xiaomi’s current share price reflects its real worth, or if the market is mispricing the story you see playing out? Xiaomi closed at HK$35.06, with a 0.5% decline over the last 7 days, a 13.0% decline over the last month and year to date, and a 7.6% decline over the last year, while the 3 year return sits at 173.5% and the 5 year return at 29.1%. These moves have kept Xiaomi on many investors’ watchlists, as price swings often prompt a closer look at what is driving...
SEHK:66
SEHK:66Transportation

How MTR’s A$2 Billion Green Bond Launch Will Impact MTR (SEHK:66) Investors

In late January 2026, MTR Corporation Limited issued two senior unsecured green bonds, a 4.886% 2030 note and a 5.582% 2038 note, each worth A$1.00 billion with fixed coupons. By tapping the green bond market at scale, MTR is reinforcing its sustainable finance credentials while broadening its access to climate-focused capital. With recent share gains as a backdrop, we’ll assess how MTR’s large green bond issuance shapes its investment narrative and funding profile. We've found 13 US stocks...